3D Tissue Models
How to Accurate Adverse Event Reporting

Fremont, CA
Learn why the single most important function of the Principal Investigator and the study conduct team is the awareness, assessment, and management of Adverse Events occurring during the conduct of clinical research with drugs or devices utilizing human subjects.

Why should you Attend: 
With the increasing complexity of the Investigational Medicinal Products (IMP's), it behooves all who have any role in observing Study Participants to know the importance of accurately collecting all AE and SAE data.

Areas Covered in the Session:
How to know what an Adverse Event is and when to report it or them
Knowing the AE types and likelihood of finding "rare" events
Understanding laboratory AEs and the "Reference Range" concept
Common Mistakes in AE / SAE Reporting

Who Will Benefit:
Principal Investigators and Sub Investigators
Clinical Research Scientists
Safety Nurses
Clinical Research Associates (CRAs) and Coordinators (CRCs)
QA / QC Auditors and Staff

Speaker Profile:
Charles H. Pierce MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. 

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Schedule of Presentations:

Tuesday, February 6, 2018
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.